26.02.2014
LANXESS Aktiengesellschaft DE0005470405
DGAP-Adhoc: LANXESS Aktiengesellschaft: Change of competitive environment leads to impairment of EUR 257 million in fourth quarter 2013; FY 2013 net income therefore negative; Planned dividend of EUR 0.50 per share
LANXESS Aktiengesellschaft / Key word(s): Preliminary Results/Dividend
26.02.2014 10:38
Dissemination of an Ad hoc announcement according to § 15 WpHG, transmitted
by DGAP - a company of EQS Group AG.
The issuer is solely responsible for the content of this announcement.
---------------------------------------------------------------------------
Change of competitive environment leads to impairment of EUR 257 million in
fourth quarter 2013; FY 2013 net income therefore negative; Planned
dividend of EUR 0.50 per share
Cologne - Specialty chemicals company LANXESS has undergone impairment
tests, according to IAS 36, that result in exceptional charges of EUR 257
million in the fourth quarter of 2013.
Due to the expected development of overcapacities, as well as raw material
and energy costs, a competitive environment is anticipated in which future
cash flow contributions no longer reflect the book values of the business
units Keltan Elastomers and High Performance Elastomers (Performance
Polymers segment), as well as Rubber Chemicals (Performance Chemicals
segment).
The impairment charges are being incurred financially in the fourth quarter
of 2013 and affect EBIT and net income in 2013. They are, however, not cash
relevant.
The above-mentioned impairment charges, together with exceptional expenses
of around EUR 30 million, brought forward within the "Advance" efficiency
program, result in a negative net income and earnings per share (EPS) in
the fourth quarter of 2013, as well as full year 2013.
The full-year net loss for 2013 is expected to be EUR 159 million.
Full-year EPS is expected to be negative at EUR 1.91. EBITDA pre
exceptionals is not subject to the impairment charges and is expected to be
EUR 735 million, within the guided range of EUR 710-760 million. The final
numbers will be provided in the 2013 consolidated financial statements that
have not yet been completed.
Subject to Supervisory Board approval, the Board of Management plans to
propose a dividend of EUR 0.50 per share for the business year 2013 at the
Annual General Meeting.
For the full year 2014, LANXESS expects a slightly improved EBITDA pre
exceptionals due alone to the absence of one-off items, even if selling
prices remain at low levels.
Cologne, February 26, 2014
Forward-Looking Statements.
This news release may contain forward-looking statements based on current
assumptions and forecasts made by LANXESS AG management. Various known and
unknown risks, uncertainties and other factors could lead to material
differences between the actual future results, financial situation,
development or performance of the company and the estimates given here. The
company assumes no liability whatsoever to update these forward-looking
statements or to conform them to future events or developments.
26.02.2014 DGAP's Distribution Services include Regulatory Announcements,
Financial/Corporate News and Press Releases.
Media archive at www.dgap-medientreff.de and www.dgap.de
---------------------------------------------------------------------------
Language: English
Company: LANXESS Aktiengesellschaft
Kennedyplatz 1
50569 Köln
Germany
Phone: +49 (0)221 8885-0
Fax: +49 (0)221 8885-4944
E-mail: [email protected]
Internet: www.lanxess.com
ISIN: DE0005470405
WKN: 547040
Indices: DAX
Listed: Regulierter Markt in Frankfurt (Prime Standard); Freiverkehr
in Berlin, Düsseldorf, Hamburg, Hannover, München, Stuttgart;
Terminbörse EUREX
End of Announcement DGAP News-Service
---------------------------------------------------------------------------
|
Weitere Ad-hoc und Unternehmensrelevante Mitteilungen zu
LANXESS Aktiengesellschaft ISIN: DE0005470405 können Sie bei EQS abrufen
Chemie , 547040 , LXS , XETR:LXS